ceoti Clinical and Experimental Ocular Trauma and Infection 2667-8462 Sertaç Argun KIVANÇ Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report Ahmed Khaqan Hussain Ameer-ud-din medical college, Lahore General hospital, Lahore Buksh Hasnain Muhammad Ameer-ud-din medical college, Lahore General hospital, Lahore https://orcid.org/0000-0002-8311-4059 Imtiaz Usman Ameer-ud-din medical college, Lahore General hospital, Lahore Rehman Ateeq-ur Ameer-ud-din medical college, Lahore General hospital, Lahore Naz Raheela Ameer-ud-din medical college, Lahore General hospital, Lahore Shabbir Usman Ameer-ud-din medical college, Lahore General hospital, Lahore 12 31 2019 1 3 126 130 05 31 2019 12 18 2019 Copyright © 2019, Clinical and Experimental Ocular Trauma and Infection 2019 Clinical and Experimental Ocular Trauma and Infection

AbstractPurpose:To analyze the outcomes of foldable capsular vitreous body injected in apost-traumatic phthysical eye.Casepresentation: A 19 year old male patient presented to ophthalmology departmentwith left post-traumatic phthisical eye , who had previously undergonecorneoscleral tear repair due to a penetrating trauma to his left eye one yearback. On ocular examination , there is a corneo scleral scar mark, aniridia ,aphakia and retina incarcerated in the scar. He was injected with a foldablecapuslar vitreous body.Conclusion:Our case report of foldable capsular vitreous body gives an excellent cosmesisfor the physical eye.

 foldable capsular vitreous body 1) Gao QY, Fu Y, Hui YN. Vitreous substitutes: challenges and directions. International journal of ophthalmology. 2015;8(3):437. 2) Lin X, Wang Z, Jiang Z, Long C, Liu Y, Wang P, Jin C, Yi C, Gao Q. Preliminary Efficacy And Safety Of A Silicone Oil–filled Foldable Capsular Vitreous Body In The Treatment Of Severe Retinal Detachment. Retina. 2012 Apr 1;32(4):729-41. 3) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006). 4) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011). 5) Swindle-Reilly, K. E. et al. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci. 50, 4840–4846 (2009). 6) Federman, J. L. & Schubert, H. D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 95, 870–876 (1988). 7) Valone Jr, J. & McCarthy, M. Emulsified anterior chamber silicone oil and glaucoma. Ophthalmology. 101, 1908–1912 (1994). 8) Ichhpujani, P., Jindal, A. & Jay Katz, L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 247, 1585–1593 (2009). 9) Foster, W. J. Vitreous Substitutes. Expert Rev Ophthalmol 3, 211–218 (2008). 10) Li, W. et al. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye (Lond). 24, 21–28 (2010). 11) Stefansson, E., Anderson, M. M., Jr, Landers, M. B., III, Tiedeman, J. S. & McCuen, B. W., II Refractive changes from use of silicone oil in vitreous surgery. Retina. 8, 20–23 (1988). 12) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011). 13) Baino, F. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater. 7, 921–935 (2011). 14) Pastor, J. C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43, 3–18 (1998). 15) Leone, G. et al. PVA/STMP based hydrogels as potential substitutes of human vitreous. J Mater Sci Mater Med. 21, 2491–2500 (2010). 16) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006). 17) Wang, P. et al. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experiment Ophthalmol. 40, e67–75 (2012). 18) Chen, J. et al. Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater. 97, 396–404 (2011). 19) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006). 20) Hara, Y. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Nihon Ganka Gakkai Zasshi. 102, 247–255 (1998). 21) Jiang, Z. et al. Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. Int J Nanomedicine.7, 1–10 (2012). 22) Jiang, Z. et al. Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro. J Ocul Pharmacol Ther. 28, 33–40 (2012). 23) Liu, Y. et al. Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body. Invest Ophthalmol Vis Sci. 51, 1636–1642 (2010). 24) Zheng, H. et al. Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol. 250, 751-759 (2012). 25) Chen, X. et al. Protein kinase Calpha downregulation via siRNA-PKCalpha released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells. Int J Nanomedicine. 6, 1303–1311 (2011).